Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Ponsoye

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nephrologie & Therapeutique|October 2, 2012
[Kidney and thyroid dysfunction]Matthieu Ponsoye, Romain Paule, Victor Gueutin, et al.
Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
Annals of the Rheumatic Diseases|February 26, 2016
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosisMatthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, et al.
Influenza and Other Respiratory Viruses|June 28, 2023
Influenza-like illness in individuals treated with immunosuppressants, biologics, and/or systemic corticosteroids for autoimmune or chronic inflammatory disease: A crowdsourced cohort study, France, 2017-2018Ségolène Greffe, Caroline Guerrisi, Cécile Souty, et al.
European Journal of Haematology|September 16, 2018
Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control studyNadege Wesner, Louis Drevon, Alexis Guedon, et al.
Rheumatology (Oxford, England)|February 2, 2022
Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?Pauline Morel, Alexandre Karras, Raphaël Porcher, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
OX40L blockade protects against inflammation-driven fibrosisMuriel Elhai, Jérôme Avouac, Anna Maria Hoffmann-Vold, et al.
Leukemia & Lymphoma|November 21, 2018
Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature reviewNadege Wesner, Louis Drevon, Alexis Guedon, et al.
Journal of Clinical Immunology|November 14, 2020
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisMathilde Roumier, Romain Paule, Alexandre Vallée, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control studyAnne Laure Roupie, Alexis Guedon, Benjamin Terrier, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nephrologie & Therapeutique|October 2, 2012
[Kidney and thyroid dysfunction]Matthieu Ponsoye, Romain Paule, Victor Gueutin, et al.
Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
Annals of the Rheumatic Diseases|February 26, 2016
Treatment with abatacept prevents experimental dermal fibrosis and induces regression of established inflammation-driven fibrosisMatthieu Ponsoye, Camelia Frantz, Nadira Ruzehaji, et al.
Influenza and Other Respiratory Viruses|June 28, 2023
Influenza-like illness in individuals treated with immunosuppressants, biologics, and/or systemic corticosteroids for autoimmune or chronic inflammatory disease: A crowdsourced cohort study, France, 2017-2018Ségolène Greffe, Caroline Guerrisi, Cécile Souty, et al.
European Journal of Haematology|September 16, 2018
Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control studyNadege Wesner, Louis Drevon, Alexis Guedon, et al.
Rheumatology (Oxford, England)|February 2, 2022
Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?Pauline Morel, Alexandre Karras, Raphaël Porcher, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 2016
OX40L blockade protects against inflammation-driven fibrosisMuriel Elhai, Jérôme Avouac, Anna Maria Hoffmann-Vold, et al.
Leukemia & Lymphoma|November 21, 2018
Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature reviewNadege Wesner, Louis Drevon, Alexis Guedon, et al.
Journal of Clinical Immunology|November 14, 2020
Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisMathilde Roumier, Romain Paule, Alexandre Vallée, et al.
Seminars in Arthritis and Rheumatism|September 8, 2020
Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control studyAnne Laure Roupie, Alexis Guedon, Benjamin Terrier, et al.
Pageof 1